Showing 2861-2870 of 9296 results for "".
- Verisante Technology, Inc. Partners with the BC Cancer Foundation to Showcase Aura™ for Skin Cancer Detectionhttps://practicaldermatology.com/news/20140623-verisante_technology_inc_partners_with_the_bc_cancer_foundation_to_showcase_aura_for_skin_cancer_detection/2459196/Verisante Technology, Inc. is partnering with the BC Cancer Foundation to showcase Verisante Aura™, a device for the detection of skin cancer. Verisante has placed an Aura™ at the Foundation's Provincial Office in Vancouver for display and educational purposes. “We are very appreciative of the BC …
- AAD Issues Statement on Sunscreen Use and Melanoma Riskhttps://practicaldermatology.com/news/20140623-aad_issues_statement_on_sunscreen_use_and_melanoma_risk/2459197/American Academy of Dermatology (AAD) President Brett M. Coldiron, MD, FAAD issued a statement about sunscreen use and melanoma in response to a study that was recently published in the journal Nature. According to the AAD, the article called attention to the fact that sunscreen alone cannot comple…
- South Beach Symposium Debuts New Host Hotelhttps://practicaldermatology.com/news/20140623-south_beach_symposium_debuts_new_host_hotel/2459198/The 13th annual meeting of the South Beach Symposium moves to the Fontainebleau Hotel in Miami Beach, February 12-16, 2015. Faculty for the event have been announced on the SBS website. There are non-overlapping CME tracks: the Masters of Pediatric Dermatology Symposium, the South Beach Clinical De…
- TruInject Injector Training System Receives Approval of Its Patenthttps://practicaldermatology.com/news/20140613-truinject_injector_training_system_receives_approval_of_its_patent/2459207/One of the key patent applications of TruInject Medical Corporation has been allowed by the US Patent Office. The patent is expected to issue shortly. The patent is for a cosmetic and therapeutic injector training system and is one of many patents filed both domestically and internationally by Tru…
- New Data Demonstrate Efficacy of ClarityMD OTC Acne Systemhttps://practicaldermatology.com/news/20140611-new_data_demonstrate_efficacy_of_claritymd_otc_acne_system/2459210/Newly published data show the efficacy of Envy Medical's ClarityMD acne system. Results of a clinical study designed by Envy, demonstrate that ClarityMD is effective in quickly and gently clearing both inflammatory and non-inflammatory acne lesions. Findings appear in the June edition of the "Jou…
- San Francisco Dermatologist Elected to AMA Board of Trusteeshttps://practicaldermatology.com/news/20140611-san_francisco_dermatologist_elected_to_ama_board_of_trustees/2459211/Jack Resneck Jr., MD, a dermatologist from San Francisco, CA, was elected to the American Medical Association (AMA) Board of Trustees. "I am honored to be elected to the AMA Board of Trustees," said Resneck. "Our AMA has an influential role to play in convening medicine, exerting influence where i…
- AAD Announces Donation of Melanoma Exposed Program from Bristol-Myers Squibbhttps://practicaldermatology.com/news/20140609-aad_announces_donation_of_melanoma_exposed_program_from_bristol-myers_squibb/2459214/Bristol-Myers Squibb donated its Melanoma Exposed™ program to the American Academy of Dermatology (AAD). The donation, provided through a charitable grant, will be used to increase public awareness of skin cancer—including melanoma, the deadliest form of skin cancer—and expand the number of free sk…
- Cosmetic Surgery Forum Unveils 2014 Agendahttps://practicaldermatology.com/news/20140606-cosmetic_surgery_forum_unveils_2014_agenda/2459216/The agenda for the 2014 Cosmetic Surgery Forum was recently unveiled. The meeting will take place from December 3 through December 6 at the Palazzo Casino and Resort in Las Vegas, NV. Under course director Joel Schlessinger, MD, this year's meeting will include sessions on cosmetic treatments for m…
- Clinical Trials Designed to Block Autophagy in Multiple Cancers, Including Melanoma, Show Promisehttps://practicaldermatology.com/news/20140606-clinical_trials_designed_to_block_autophagy_in_multiple_cancers_including_melanoma_show_promise/2459217/In the largest group of results to date, researchers from Penn Medicine's Abramson Cancer Center and other institutions announced that they have shown in clinical trials that the malaria drug hydroxychloroquine (HCQ) blocked autophagy in a host of aggressive cancers—glioblasto…
- Synera Approved for At-Home Use to Prevent Needle Stick Discomforthttps://practicaldermatology.com/news/20140604-synera_approved_for_at-home_use_to_prevent_needle_stick_discomfort/2459219/The FDA approved a labeling change that allows Galen US Incorporated's Synera (lidocaine and tetracaine) topical patch to be used at home. Synera is a technological advance that can help prevent needle stick pain associated with superficial IVs and superficial dermatological p…